Cancer

B. Yetkin-Arik, S. A. Jansen, S. Varderidou-Minasian, et al. Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage. Stem Cell Research & Therapy. 2024;15(1):125. doi:10.1186/s13287-024-03738-9

Riyue Bao, Alan Hutson, Anant Madabhushi, et al. Ten challenges and opportunities in computational immuno-oncology. Journal for ImmunoTherapy of Cancer. 2024;12(10):e009721. doi:10.1136/jitc-2024-009721

Xuexue Xie, Xinyu Li, Wei Song. Tumor organoid biobank-new platform for medical research. Scientific Reports. 2023;13(1):1819. doi:10.1038/s41598-023-29065-2

Elena Kromidas, Alicia Geier, Adrian Weghofer, Hui-Yu Liu, Martin Weiss, Peter Loskill. Immunocompetent PDMS-Free Organ-on-Chip Model of Cervical Cancer Integrating Patient-Specific Cervical Fibroblasts and Neutrophils. Advanced Healthcare Materials. 2023:2302714. doi:10.1002/adhm.202302714

Tao Zhang, Liang Zhuang, Munawaer Muaibati, et al. Identification of cervical cancer stem cells using single-cell transcriptomes of normal cervix, cervical premalignant lesions, and cervical cancer. eBioMedicine. 2023;92. doi:10.1016/j.ebiom.2023.104612

Abdullah O. Khan, Antonio Rodriguez-Romera, Jasmeet S. Reyat, et al. Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies. Cancer Discovery. 2023;13(2):364-385. doi:10.1158/2159-8290.CD-22-0199

Eliana Steinberg, Roy Friedman, Yoel Goldstein, et al. A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine. Communications Biology. 2023;6(1):1-14. doi:10.1038/s42003-023-05531-5

Burcu Firatligil-Yildirir, Ozden Yalcin-Ozuysal, null Nonappa. Recent advances in lab-on-a-chip systems for breast cancer metastasis research. Nanoscale Advances. 2023;5(9):2375-2393. doi:10.1039/d2na00823h

Naira Baregamian, Konjeti R. Sekhar, Evan S. Krystofiak, et al. Engineering functional 3-dimensional patient-derived endocrine organoids for broad multiplatform applications. Surgery. 2023;173(1):67-75. doi:10.1016/j.surg.2022.09.027

Laura Rüland, Francesco Andreatta, Simone Massalini, et al. Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. Nature Communications. 2023;14(1):2377. doi:10.1038/s41467-023-37951-6